» Articles » PMID: 20220206

Choline Intake Exceeding Current Dietary Recommendations Preserves Markers of Cellular Methylation in a Genetic Subgroup of Folate-compromised Men

Overview
Journal J Nutr
Publisher Elsevier
Date 2010 Mar 12
PMID 20220206
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Severe choline deficiency adversely affects cellular methylation and DNA integrity, with potentially serious implications for disease risk. As part of a 12-wk controlled choline intervention study conducted in folate-compromised Mexican-American men (n = 60; 18-55 y) differing in the methylenetetrahydrofolate reductase (MTHFR) C677T genotype (21 677CC, 29 677TT), this study evaluated the effects of varied choline intakes (300, 550, 1100, and 2200 mg/d) on the change (i.e. wk 12-0) in markers of cellular methylation and DNA integrity. Choline intake affected the change in plasma S-adenosylmethionine (P = 0.044), with decreases tending to be greater (P < or = 0.08) in the 300 and 550 mg/d groups than in the 2200 mg/d group. Choline intake also interacted with the MTHFR C677T genotype to affect the change in genomic DNA methylation and DNA damage. In men with the MTHFR 677CC genotype, choline intake affected (P = 0.007) the change in DNA methylation, with a greater decrease (P < 0.02) in the 300 mg/d group than in the 1100 and 2200 mg/d groups. In men with the MTHFR 677CC genotype, choline intake also affected (P = 0.047) the change in DNA damage, with the increase tending to be greater (P = 0.07) in the 550 mg/d group than in the 2200 mg/d group. Choline intake did not affect these variables in men with the MTHFR 677TT genotype. Overall, these data suggest that choline intake exceeding current dietary recommendations preserves markers of cellular methylation and attenuates DNA damage in a genetic subgroup of folate-compromised men.

Citing Articles

Prenatal Choline Supplementation Improves Glucose Tolerance and Reduces Liver Fat Accumulation in Mouse Offspring Exposed to Ethanol during the Prenatal and Postnatal Periods.

Kadam I, Trasino S, Korsmo H, Lucas J, Pinkas M, Jiang X Nutrients. 2024; 16(9).

PMID: 38732511 PMC: 11085373. DOI: 10.3390/nu16091264.


Holistic Integration of Omics Tools for Precision Nutrition in Health and Disease.

Ramos-Lopez O, Martinez J, Milagro F Nutrients. 2022; 14(19).

PMID: 36235725 PMC: 9572439. DOI: 10.3390/nu14194074.


Epigenetic Modifications and Their Potential Contribution to Traumatic Brain Injury Pathobiology and Outcome.

Zima L, West R, Smolen P, Kobori N, Hergenroeder G, Choi H J Neurotrauma. 2022; 39(19-20):1279-1288.

PMID: 35481812 PMC: 9529317. DOI: 10.1089/neu.2022.0128.


Maternal Choline Supplementation and High-Fat Feeding Interact to Influence DNA Methylation in Offspring in a Time-Specific Manner.

Korsmo H, Dave B, Trasino S, Saxena A, Liu J, Caviglia J Front Nutr. 2022; 9:841787.

PMID: 35165655 PMC: 8837519. DOI: 10.3389/fnut.2022.841787.


The Effects of Dietary Interventions on DNA Methylation: Implications for Obesity Management.

Maugeri A Int J Mol Sci. 2020; 21(22).

PMID: 33212948 PMC: 7698434. DOI: 10.3390/ijms21228670.


References
1.
Yao Z, Vance D . The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J Biol Chem. 1988; 263(6):2998-3004. View

2.
Hensley K, Kotake Y, Sang H, Pye Q, Wallis G, Kolker L . Dietary choline restriction causes complex I dysfunction and increased H(2)O(2) generation in liver mitochondria. Carcinogenesis. 2000; 21(5):983-9. DOI: 10.1093/carcin/21.5.983. View

3.
Li Z, Agellon L, Allen T, Umeda M, Jewell L, Mason A . The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metab. 2006; 3(5):321-31. DOI: 10.1016/j.cmet.2006.03.007. View

4.
Zeisel S, Blusztajn J . Choline and human nutrition. Annu Rev Nutr. 1994; 14:269-96. DOI: 10.1146/annurev.nu.14.070194.001413. View

5.
Niculescu M, Yamamuro Y, Zeisel S . Choline availability modulates human neuroblastoma cell proliferation and alters the methylation of the promoter region of the cyclin-dependent kinase inhibitor 3 gene. J Neurochem. 2004; 89(5):1252-9. PMC: 1592524. DOI: 10.1111/j.1471-4159.2004.02414.x. View